Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BiogenSeattle GeneticsModernaNOVOZYMES A/S/SBioNTech
Price Information
Current Price$278.70$174.35$62.61$58.48$65.61
52 Week RangeHoldBuyBuyHoldHold
Beat the Market™ Rank
Overall Score1.
Analysis Score3.
Community Score3.
Dividend Score0.
Ownership Score1.
Earnings & Valuation Score2.
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldHold
Consensus Price Target$309.63$148.28$65.91N/A$43.56
% Upside from Price Target11.10% upside-14.95% downside5.27% upsideN/A-33.61% downside
Trade Information
Market Cap$45.48 billion$31.36 billion$24.12 billion$17.21 billion$14.85 billion
Average Volume2,147,3561,080,77814,195,72026,5902,137,185
Sales & Book Value
Annual Revenue$14.38 billion$916.71 million$60.21 million$2.28 billion$121.63 million
Price / Sales3.1632.92386.027.62122.05
Cashflow$38.65 per shareN/AN/A$1.74 per shareN/A
Price / Cash7.21N/AN/A33.66N/A
Book Value$73.93 per share$10.95 per share$3.49 per share$6.10 per share$2.44 per share
Price / Book3.7715.9217.949.5926.89
Net Income$5.89 billion$-158,650,000.00$-514,020,000.00$511 million$-200,540,000.00
Trailing P/E Ratio8.60N/AN/A35.99N/A
Forward P/E Ratio8.63N/A1,252.2033.61N/A
P/E Growth$0.60N/AN/A$25.89N/A
Net Margins40.76%-32.81%-963.84%N/AN/A
Return on Equity (ROE)49.22%-16.51%-37.49%N/AN/A
Return on Assets (ROA)24.26%-13.88%-29.24%N/AN/A
Annual PayoutN/AN/AN/A$0.52N/A
Dividend YieldN/AN/AN/A0.89%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.39%N/AN/AN/AN/A
Current Ratio1.73%4.51%9.29%N/A3.47%
Quick Ratio1.54%4.18%9.29%N/A3.40%
Ownership Information
Institutional Ownership Percentage87.45%94.33%52.01%0.13%2.92%
Insider Ownership Percentage0.54%31.10%29.20%N/AN/A
Shares Outstanding163.19 million173.10 million371.22 million297.00 million226.26 million
Next Earnings Date7/22/2020 (Confirmed)7/30/2020 (Confirmed)8/5/2020 (Estimated)8/13/2020 (Estimated)N/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.